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background:  Acute kidney injury following transcatheter aortic valve replacement (TAVR) requiring initiation of renal replacement therapy 
(RRT) is not well studied. We sought to determine the incidence and clinical outcomes of patients initiated on RRT following TAVR.
methods:  We included all consecutive patients with severe aortic stenosis (AS) who underwent successful TAVR with the Edwards 
Sapien valve at our tertiary care center from March 2012 to April 2014. We excluded patients on maintenance RRT pre-TAVR. Baseline 
characteristics and Valve Academic Research Consortium (VARC-2) outcomes in patients initiated on RRT during index hospitalization 
were compared to patients who did not require RRT. Mann-Whitney Test and Fisher’s exact tests were used for statistical analysis.
results:  We included 191 patients in our registry. RRT was initiated in 7 (3.7%) patients post-TAVR. RRT patients had a higher mean 
pre-TAVR creatinine (1.7 vs. 1.1 mg/dL, p=0.036), Society of Thoracic Surgeons (STS) scores (18.9 vs. 9.6, p=0.038), incidence of low-
left-ventricular-flow low-aortic-valve-gradient (LFLG) (71.4% vs. 20.7%, p=0.007) but no difference in mean ejection fraction (EF) (43.6% 
vs. 52.6%, p=0.078). RRT patients were transfused a higher mean number of packed red-blood cells (11 vs. 2 units, p<0.001) and had 
a non-significant trend toward major/life threatening bleeding (71% vs. 44%, p= 0.248). RRT patients were also found to have higher 
overall vascular complications (100% vs. 59.8%, p=0.044), 30-day readmission (42% vs. 4%, p=0.003), 30-day mortality (42.9% vs. 3.8%, 
p=0.003) and one-year mortality (85.7% vs. 10.9%, p<0.001).
Conclusion:  Initiation of RRT following TAVR was an uncommon event, occurring in patients with higher STS scores. This was associated 
with higher vascular complications, units of blood transfused, and dismal outcomes including high rate of 30-day re-admission and mortality 
at 30 days and 1 year. Larger registries are warranted to identify predictors for patients at risk for initiation of RRT where TAVR maybe 
futile given the excessively high 1-year mortality. In addition, peri-procedural optimization is warranted to safely reduce short and long-term 
mortality.
